rpr102681
Studies associated with:
| Division | Study Number | Title | Investigator(s) | Release Date |
|---|---|---|---|---|
| DTMC | NIDA-CPU-0003 | Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681 | Louis Cantilena, Jr., M.D, Ph.D. |